7-ADD

7-ADD

7-ADD (7-Aminoclonazepam)

 

PRODUCT DETAILS TABLE

 

 

Specification Details
Brand Biosynlab
Product Name 7-ADD (7-Aminoclonazepam)
IUPAC Name 7-amino-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
CAS Number 4928-02-3
Molecular Formula C₁₅H₁₂ClN₃O
Molecular Weight 285.73 g/mol
Chemical Class Benzodiazepine metabolite / 1,4-benzodiazepin-2-one
Purity ≥99.0% (HPLC Verified)
Appearance White to pale yellow crystalline powder
Melting Point 238-242°C (decomposition)
Solubility Soluble in DMSO, methanol; sparingly soluble in ethanol
Storage -20°C, desiccated, away from light
Packaging Amber glass vial with PTFE seal
Quantities 100mg, 250mg, 500mg, 1g, 5g, bulk
Analysis COA, NMR, MS, FTIR included
Shipping Express courier, tracked, discreet
Regions USA, UK, Germany, Netherlands, EU, Canada

Introduction

7-ADD (7-Aminoclonazepam) represents a critical benzodiazepine metabolite that serves as an essential analytical standard in forensic toxicology, clinical pharmacology, and benzodiazepine metabolism research. As the primary pharmacologically active metabolite of clonazepam (Klonopin), 7-aminoclonazepam offers unique insights into cytochrome P450-mediated biotransformation pathways and structure-activity relationships within the 1,4-benzodiazepine chemical class. Biosynlab delivers pharmaceutical-grade 7-ADD with certified ≥99.0% purity, supporting cutting-edge research across USA, United Kingdom, European Union, and international scientific markets.

The metabolic transformation of the nitro group at the 7-position of clonazepam to an amino group represents a key biotransformation pathway mediated primarily by CYP3A4 enzymes. This reduction produces 7-aminoclonazepam, which retains significant pharmacological activity and contributes to the overall clinical effects of the parent compound. Researchers at forensic laboratories in London, Berlin, Amsterdam, New York, and Los Angeles utilize Biosynlab 7-ADD for quantitative analysis in biological matrices, metabolite identification studies, and therapeutic drug monitoring applications.

Showing the single result